Skip to main content
Clinical Trials/NCT00221663
NCT00221663
Terminated
Phase 2

Clinical Trial Comparing a Conventional Median Sternotomy Versus a Minimally Invasive Technique for Aortic Valvular Replacement in Adults

University Hospital, Bordeaux1 site in 1 country78 target enrollmentJanuary 2002

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Heart Valve Diseases
Sponsor
University Hospital, Bordeaux
Enrollment
78
Locations
1
Primary Endpoint
Forced expiratory volume and peak expiratory volume/second
Status
Terminated
Last Updated
17 years ago

Overview

Brief Summary

Minimally-invasive operative techniques have been introduced in cardiac surgery. These techniques may have several advantages such as a decrease in post operative pain, lower morbidity and mortality, faster recovery, and a shorter hospital stay. However, these advantages have rarely been documented in the setting of a formal randomized controlled trial.

Detailed Description

Background: Minimally invasive techniques for cardiac surgery should be formally evaluated. Design: Randomized, single-blind, monocentric trial. Interventions Compared: Median sternotomy versus minimally invasive technique. Eligibility Criteria: Indication of isolated aortic valvular replacement, preoperative American Society of Anesthesiologists (ASA) class \< = 3, left ventricular ejection fraction \> = 40%. Primary Outcome: Forced expiratory volume and peak expiratory volume/second at 48 hours.

Registry
clinicaltrials.gov
Start Date
January 2002
End Date
December 2006
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux

Eligibility Criteria

Inclusion Criteria

  • Indication of isolated aortic valvular replacement
  • Preoperative ASA class \< = 3
  • Left ventricular ejection fraction \> = 40%
  • Signed informed consent

Exclusion Criteria

  • Aortic or mitral insufficiency \> 3
  • History of cardiac surgery
  • Acute pulmonary edema
  • Endocarditis
  • Chronic renal insufficiency decompensation
  • Operative coagulation disorders regardless of etiology

Outcomes

Primary Outcomes

Forced expiratory volume and peak expiratory volume/second

Time Frame: at 48 hours

Secondary Outcomes

  • Forced expiratory volume(at 24 hours)
  • Peak expiratory volume/s at 24 hours
  • Pro-inflammatory cytokines on tracheal aspiration samples
  • Transfusion requirements during the first 24 hours post operative
  • Hemodynamic parameters
  • Duration of surgery extracorporeal circulation (ECC) and aortic-cross-clamp-time
  • Consumption of analgetics
  • Morbidity and mortality during hospital stay

Study Sites (1)

Loading locations...

Similar Trials